Rest of Arrhythmia after LQTS Panel
New York
Approved
Genes
Conditions
- Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
- Long QT Syndrome (LQTS)
- Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- Short QT Syndrome (SQTS)
- Brugada Syndrome
Clinical Utility
- Molecular confirmation of a clinical diagnosis in symptomatic individuals
- Risk assessment of asymptomatic family members of a proband with arrhythmia
- Differentiation of hereditary arrhythmia from acquired (non-genetic) arrhythmia
- Recurrence risk calculation
Lab Method
- Next-Gen Sequencing
- ExonArray CGH
Test Code
727RE
CPT Codes*
81439x1
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing